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doi:10.1Objective: Recurrence rates as high as 30% have been observed 6 months after treatment of chronic ischemic
mitral regurgitation (CIMR) with isolated annuloplasty. We postulated that the high early recurrence rates
resulted from the presence of untreated pseudoprolapse of the anterior leaflet.
Methods: We conducted a retrospective study of all mitral valve repairs for CIMR performed by a single sur-
geon (S.W.H.) from 1995 to 2011. After annuloplasty, Gore-Tex neochordae were added if the high-pressure
saline test indicated the presence of pseudoprolapse of the anterior leaflet.
Results:A total of 47 patients underwent mitral valve repair for CIMR. Of the 47 patients, 24 (51%) were found
to have pseudoprolapse requiring the addition of neochordae. For all patients, the average age was 65.1 years,
and 65.2%were men. Fourteen (30%) had had a preoperative intra-aortic balloon pump placed by cardiologists.
Fourteen (30%) had severe pulmonary hypertension. Concomitant coronary artery bypass grafting was per-
formed in 40 patients, with an average of 2.2 grafts; 7 had previously undergone coronary artery bypass grafting.
Mitral Carpentier-Edwards physio annuloplasty rings were used in all patients with a mean size of 29 mm. One
patient died postoperatively. Follow-up data were available for all 47 patients at an average of 4.9 years. The
5-year survival rate was 82.5%. The mean pre- and postoperative New York Heart Association class, ejection
fraction, and mitral regurgitation grade were 3 and 1.52 (P<.0001), 34% and 41% (P ¼ .0006), and 3.51 and
1.08 (P<.0001), respectively. Two patients developed greater than moderate mitral regurgitation.
Conclusions: Effective repair of CIMR should include surgical techniques to correct pseudoprolapse of the an-
terior leaflet, when present. The selective addition of Gore-Tex neochordae to an undersized annuloplasty nearly
eliminates recurrent regurgitation aftermitral valve repair forCIMR. (J ThoracCardiovasc Surg 2012;143:S33-7)The prognosis of patients with ischemic heart disease is
negatively affected by the presence of mitral regurgitation
(MR). An increasing severity of regurgitation is associated
with a progressively worse 5-year survival.1 The current
recommendations for the treatment of moderate to severe
chronic ischemic mitral regurgitation (CIMR) support the
repair or replacement of the mitral valve in addition to cor-
onary revascularization.2-4 Reduction mitral annuloplasty
using a flexible ring (1 size smaller than measured)
has been associated with recurrence rates of up to 30%
within 6 months.5,6
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The Journal of Thoracic and Carechocardiogram (TEE), we hypothesized that a functional
prolapse of the anterior leaflet was a major cause of re-
currence of regurgitation after a seemingly successful re-
pair. This functional prolapse results from the anterior
leaflet overriding the posterior leaflet, either below the
annulus (Carpentier IIIB) or above the annulus (Carpent-
ier II).7 The term ‘‘pseudoprolapse’’ was coined to de-
scribe the functional prolapse seen in ischemic MR
with normal leaflets and to differentiate it from the classic
prolapse of myxomatous MR associated with excess leaf-
let tissue.
The dominant strategy at our institution has been to iden-
tify pseudoprolapse, correct it with Gore-Tex neochordae,
and use a single-undersized rigid annuloplasty ring. The
present report analyzes the outcome of all patients at our in-
stitution who underwent mitral repair for CIMR by a single
surgeon (S.W.H.) using isolated annuloplasty or annulo-
plasty with neochordae.MATERIALS AND METHODS
The institutional review board of Yale University reviewed and ap-
proved the present study with a waiver of consent. From 1995 to 2011,
47 patients were identified who underwent surgical treatment for CIMR, in-
cluding coronary artery bypass grafting and mitral valve repair. Postoper-
ative echocardiographic studies were available for 42 patients, with
a mean follow-up of 2.5 years. The degree of MR was classified as 0, ab-
sent; 1, mild; 2, moderate; 3, moderate-severe; and 4, severe.diovascular Surgery c Volume 143, Number 4S S33
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S3Abbreviations and Acronyms
CIMR ¼ chronic ischemic mitral regurgitation
LVEDD ¼ left ventricular end-diastolic dimension
MR ¼ mitral regurgitation
NYHA ¼ New York Heart Association
TEE ¼ transesophageal echocardiogramThe perioperative demographics and risk factors were determined from
the patient charts. Postoperative echocardiographic follow-up data were
collected from hospital records and reports supplied by cardiologists or pri-
mary care physicians. No reinterpretation of the studies was performed to
avoid the introduction of bias.
Follow-up data were available for all 47 patients, with a mean of 4.90
years (range 3.75 to 6.06). Mortality data were obtained by chart review,
telephone calls to the patients’ families, and from the United States Social
Security Death Index.
A subgroup analysis was performed using the left ventricular end-
diastolic dimension (LVEDD) of greater or less than 6 cm.
Surgical Technique
Our repair strategy included the following: ring sutures were placed.
One or 2 Gore-Tex neochordae were anchored to the papillary muscle.
The anterior leaflet surface area was measured and a 1-downsized
Carpentier-Edwards physio (Edwards, Irvine, Calif) annuloplasty ring
was seated. The valve was tested with high-pressure saline injection into
the left ventricle. If a leak was identified or if an asymmetric line of coap-
tation was present, the involved area was marked with ink. The chordae
were then passed through the inked area. A simple edge-to-edge Prolene
stitch was placed and the knot was used as a reference for tying down
the Gore-Tex neochordae. The Prolene edge to edge stitch was then
removed and the ring sutures were tied. The final steps were repeated until
a perfect line of closure was obtained.
Statistical Analysis
Independent statistical analysis was performed using SAS, version 9.2
(SAS Institute, Cary, NC). The data are presented as the mean and 95%
confidence intervals (CIs). The mean values were compared using paired
t tests. Signed rank tests were also performed on the ordinal variables,
the NYHA class and MR grade. The t tests were used to test the equality
of mean differences in these measures between the LVEDD groups
(LVEDD<6 cm versus LVEDD6 cm). The survival rates were compared
using the Kaplan-Meier estimates and the log-rank test. P<.05 was used as
the threshold for statistical significance in all tests.
RESULTS
Demographics
From 1995 to 2011, 47 patients underwent mitral valve
repair for CIMR. Of the 47 patients, 23 (49%) underwent
isolated undersized annuloplasty and 24 (51%) underwent
annuloplasty with neochordae. The average age was 66
years, and 64% were men. Fourteen patients (30%) had
an intra-aortic balloon pump placed by cardiologists before
surgery, and 14 patients (30%) had severe pulmonary
hypertension (systolic blood pressure>60 mm Hg).
Concomitant coronary artery bypass grafting was per-
formed in 40 patients with an average of 2.2 grafts. The
remaining 7 had undergone previous coronary artery4 The Journal of Thoracic and Cardiovascular Surgbypass grafting. Mitral Carpentier-Edwards physio rings
were used in all patients with a mean size of 29 mm
and median size of 28 mm. The average crossclamp and
cardiopulmonary bypass time was 91 and 125 minutes,
respectively.
Of the 47 patients, 24 (51%) were found to have pseu-
doprolapse of the anterior leaflet requiring neochordae in
addition to annuloplasty. The locations of the neochor-
dae were A2 (n ¼ 2), A3 (n ¼ 12), and A2 plus A3
(n ¼ 10).
Outcomes
One patient died on postoperative day 28 secondary to
pulmonary failure. One patient experienced a stroke and
one developed a sternal wound infection.
The mean pre- and postoperative values are listed in
Table 1. Significant difference were found in the values
for NYHA, ejection fraction, and MR at 3 and 1.52 (P<
.0001), 34% and 41% (P ¼ .0006), and 3.51 and 1.08
(P<.0001), respectively.
Echocardiographic follow-up demonstrated 2 recur-
rences with greater than 2þMR. Both occurred within 1
year after surgery, 1 in each subgroup. No late recurrences
developed. The freedom from recurrence rate during the
follow-up period was 92.7% (95% CI 82.9% to 100%;
Figure 1, B).
The primary endpoint was all-cause mortality. Twelve
patients died during the follow-up period. Two patients un-
derwent cardiac transplantation, both without MR. The
overall 5-year survival rate was 82.5% (95% CI 69.3%
to 95.7%) at 4.9 years (Figure 1, C). The median survival
time for the overall population was 10.74 years.
Subgroup Analysis
Nineteen patients with a LVEDD of 6 cm or greater had
significant preoperative to postoperative improvement in
the LVEDD from 6.63 to 6.23 cm (P¼ .04), left ventricular
ejection fraction from 26% to 35% (P ¼ .0103), NYHA
class from 3.06 to 1.61 (P< .001), and MR grade from
3.68 to 1.16 (P<.001). A trend for a decrease in the left ven-
tricular end-systolic dimension was seen (from 5.74 preop-
eratively to 5.05 cm postoperatively, P ¼ .0850) without
reaching statistical significance.
Twenty-eight patients with a LVEDD of less than 6 cm
had significant preoperative to postoperative improvement
in the left ventricular ejection fraction from 39% to 46%
(P ¼ .0269), NYHA class from 2.95 to 1.45 (P< .001),
and MR grade from 3.39 to 1.0 (P  .001). No difference
was seen in LVEDD (5.07 vs 5.26 cm, P ¼ .690) or left
ventricular end-systolic dimension (3.64 vs. 3.86 cm,
P ¼ .457).
Mid-term follow-up data were available for all patients in
the subgroup analysis. The 5-year survival rate in the 6-cm
or greater LVEDD group was 70.5% (95% CI 45% toery c April 2012




P valueMean 95% CI Mean 95% CI
EF (%) 34 0.30–0.38 41 0.36–0.45 .0006
LVEDD 5.80 5.48–6.12 5.68 5.38–5.97 .2449
LVESD 4.58 4.16–4.99 4.36 3.97–4.74 .1944
LA Diameter 4.67 4.37–4.97 4.75 4.35–5.15 .2722
MR Grade 3.51 3.35–3.67 1.08 0.74–1.41 <.0001
NYHA Class 3.00 2.76–3.24 1.52 1.25–1.78 <.0001
CI, confidence interval; EF, ejection fraction; LA, left atrial; LVEDD, left ventricular
end-diastolic dimension; LVESD, left ventricular end-systolic dimension;MR, mitral
regurgitation; NYHA, New York Heart Association.
Hashim et al Mitral Valve Prolapse95.9%) and was 91% (95% CI 79% to 100%) in the less
than 6-cm LVEDD group.
Using the log-rank test, a trend was found for improved
survival for the less than 6-cm group compared with the
6-cm or greater group (log-rank P ¼ .64) without reaching
statistical significance (Figure 1, D).FIGURE 1. A, Top, Ideal coaptation of anterior and posterior mitral valve leafl
riding of the posterior leaflet by the anterior leaflet. B, Overall freedom from re
cording to left ventricular end-diastolic dimension (LVEDD) greater than 6 or
The Journal of Thoracic and CarDISCUSSION
Ischemic remodeling results in subtle, yet complex, geo-
metric changes of the ventricle and papillary muscles that
negatively affect ventricular function and mitral valve com-
petence.8,9 Clues regarding the pattern of regurgitation were
taken from the echocardiographic studies.10,11 In CIMR, the
transthoracic echocardiogram typically shows a central
regurgitant jet. However, on intraoperative TEE, an
eccentric jet was commonly detected, either isolated or
combined with a central jet. This eccentric jet was always
posteriorly directed, revealing the presence of functional
anterior prolapse.
The treatment of CIMR has relied on an undersized annu-
loplasty using a small-size ring to reduce the anteroposte-
rior diameter of the annulus and increase the coaptation
surface. A high early recurrence rate of up to 30% has
been observed using this technique.5,6 It is safe to assume
that in those series, the intraoperative saline test results
were satisfactory, and the patients had no intraoperativeets. A, Bottom, Pseudoprolapse of anterior leaflet as demonstrated by over-
currence. C, Five-year overall survival. D, Subgroup survival analysis ac-
less than 6 cm.
diovascular Surgery c Volume 143, Number 4S S35
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after surgery might have been the consequence of an
insufficient surface of coaptation in the face of the
increased loading conditions associated with patients
resuming their normal activity.
Braun and colleagues,12 aware of the limitation of the
undersized annuloplasty technique, proposed the use of re-
strictive annuloplasty that downsized the ring by 2 sizes in-
stead of 1. Although restrictive annuloplasty might add 1
or 2 mm to the surface of coaptation, it has been shown
to produce mitral stenosis,13,14 with gradients up to 8
mm Hg or more at rest.15 In 1 series, 80% of the recur-
rences after restricted annuloplasty were associated with
restricted posterior leaflet motion.15 This finding would
suggest that the recurrences could have been prevented if
the alignment of the leaflets had been restored in the orig-
inal operation.
Carpentier, McCarthy, and Adams, recognizing the
asymmetric coaptation at the level of P3, designed the
IMR ETlogix (Edwards, Irvine CA) ring, which added ad-
ditional narrowing of the anteroposterior diameter in the
area corresponding to P2-P3.16 The goal of this measure
was to increase the coapting surface of the leaflets at their
points of asymmetry without resorting to the use of a restric-
tive ring. However, the shape of the IMR ring predeter-
mined the location of the asymmetry in the leaflets and
did not always correlate with the anatomy of a particular
patient.17
Kron and colleagues18 advocated relocating the posterior
papillary muscle closer to the annulus. This technique has
proved efficacious in treating MR associated with inferior
wall myocardial infarction, but it does not address MR sec-
ondary to anterior wall myocardial infarction. Others have
proposed adjunctive techniques such as secondary chord
cutting,19 papillary muscle sling,20 and papillary muscle
relocation and leaflet augmentation.21,22 Each of these
techniques addresses a particular anatomic setting.23 The
current inconsistent and incomplete success of repair tech-
niques has led the National Heart, Lung, and Blood Institute
to initiate a prospective trial of mitral repair versus replace-
ment for the treatment of ischemic MR.24
In our approach to CIMR, we have applied the same prin-
ciple of leaflet alignment that has been used in the treatment
of myxomatous MR. Our strategy was based on the recog-
nition that in a subgroup of ischemic patients, there is
a pseudoprolapse of the anterior leaflet. This pseudopro-
lapse, if uncorrected, would lead to a recurrence of MR.25
Without addressing the pseudoprolapse, an isolated annulo-
plasty could only produce a partial apposition of the in-
verted portions of the leaflets. In contrast, treatment of the
pseudoprolapse with a realignment of the planes of the op-
posing leaflets would allow the annuloplasty to achieve
100% of the possible coaptation. Correction of the anterior
pseudoprolapse was achieved with Gore-Tex neochordaeS36 The Journal of Thoracic and Cardiovascular Surgapplied to A3 or A2, or both. All patients with CIMR,
whether presenting with type II or IIIB regurgitation,
were approached with the same strategy and surgical
technique.
During the repair, we challenged the coaptation line with
high-pressure saline injection to detect any protrusion of the
anterior leaflet at the level of A3 and/or A2, especially if
an eccentric jet had been detected on the intraoperative
TEE. Any asymmetric closure, even without a leak
(Figure 1, A), was corrected with neochordae. The use of
a temporary edge-to-edge suture facilitated an exact mea-
surement of the length of Gore-Tex neochordae and precise
leaflet alignment. This adjunct technique was an essential
step because ischemic patients, unlike myxomatous pa-
tients, have no excess leaflet tissue to compensate for
misalignment.
We were concerned that, in Carpentier type IIIB, the line
of coaptation falling below the plane of the annulus would
produce interscallop regurgitation and that the continued
ventricular remodeling would lead to MR recurrence. The
results of our study have alleviated both of these concerns.
Correcting the pseudoprolapse in ischemic MR achieved
the near elimination of recurrence and improved midterm
survival. In our series, no late recurrences developed,
even though 34% of our patients exhibited postrepair ven-
tricular enlargement. The only 2 instances of recurrence
developed during the first year after surgery, suggesting
technical failure of the repair rather than a remodeling eti-
ology. Our 93% 5-year freedom from recurrence rate
strongly suggests that ventricular remodeling does not re-
sult in MR recurrence. The ventricular enlargement that
has followed other repair techniques is most likely a conse-
quence, rather than a cause, of the failed repairs.26 Our data
have not confirmed the findings by others of reverse remod-
eling that occurs after the correction of MR. When we ana-
lyzed the 2 groups, the only statistically significant result
was that of regression of LVEDD in the larger (>6 cm)
ventricles.
Our results indicate that the preoperative TEE can be
used to guide operative strategies. Some patients with ische-
mic MR have no pseudoprolapse, and the TEE will show
a central jet that corresponds to symmetric dilation of the
annulus. In those patients, a simple undersized annuloplasty
should suffice. In contrast, in patients with CIMR and pseu-
doprolapse of the anterior leaflet, TEE will reveal an eccen-
tric or dual jet. In this subgroup of patients, neochordae
should be used in addition to annuloplasty. We recommend
that a preoperative TEE be performed in all patients with
CIMR. If the TEE shows an eccentric jet pattern, patients
should be referred to surgeons who are practiced in anterior
leaflet repair.
The authors would like to thank Maria Ciarleglio for her assis-
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